![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » MILLENNIUM OUTBIDS GENZYME FOR ANORMED
MILLENNIUM OUTBIDS GENZYME FOR ANORMED
Millennium Pharmaceuticals has outbid Genzyme Corp. to acquire AnorMed, offering $515 million for the biotech firm. Early Tuesday, Millennium said it intends to buy Vancouver-based AnorMed for $12 a share, or a 21% premium over AnorMed's Monday closing price. AnorMed said that its board has agreed to the transaction and will recommend that stockholders tender their shares into the offer.
Market Watch (http://www.marketwatch.com/News/Story/Story.aspx?dist=newsfinder&siteid=google&guid=%7BC23E884D-B523-4536-B73B-3F1DB378DC2A%7D&keyword=)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
11Jul
-
18Jul
-
21Oct